Request Information

If you are a physician and would like to learn more about PancraGEN®, PanDNA®, or Interpace Diagnostics services, you can reach us using the form below.
I am interested in:
(Needed for verification purposes to allow representative follow‑up)

Limitations and Disclaimers1
Although PancraGEN is highly specific for malignancy, some malignant cysts may not be detected. There may also be individuals who are falsely identified as having a malignant cyst. Diagnosis and appropriate patient management are the responsibility of the referring physician or health care provider.

Reference 1. Al-Haddad MA, Kowalski T, Siddiqui A, et al. Integrated molecular pathology accurately determines the malignant potential of pancreatic cysts. Endoscopy. 2015;47(2):136-142. 

Interpace Diagnostics is a registered trademark and business unit of Interpace Biosciences, Inc.™
©2021 Interpace Biosciences, Inc.™ All rights reserved.
Privacy Policy | HIPAA Privacy

Scroll to Top

You are about to view an excerpt
from this webinar.

You can explore the full webinar using the Excerpt Menu.

Got it!